Drug Approval | July 24, 2022
SMS Pharmaceuticals receives approval for Ibuprofen by EDQM
With this, the company can start selling Ibuprofen in the European markets.
With this, the company can start selling Ibuprofen in the European markets.
This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times
It posted net profit of Rs.60.96 crores for the 12 months period ended March 31, 2021
The company posted net profit of Rs.7.61 crores for the period ended December 31, 2019.
The inspection concluded with one minor observation in Form 483
The approval by the US FDA comes after extensive safety testing and manufacturing improvements
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
The inspection conducted by EDQM at its Visakhapatnam facility
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
_256_384.jpg)
The Indian companies that have been granted licences are Cipla, Sun Pharma, Laurus Labs, Divis Labs, Glenmark, Cadila, Torrent, Emcure, McLeods, SMS Pharmaceuticals, Strides, Biocon, Aurobindo Pharma, Hetero, Granules, Amneal, MSN, Arene Life Sciences and Viatris
Subscribe To Our Newsletter & Stay Updated
